R-(+)-Lactamide 97+% cp 98+% ee
Catalog No: FT-0678220
CAS No: 598-81-2
- Chemical Name: R-(+)-Lactamide 97+% cp 98+% ee
- Molecular Formula: C3H7NO2
- Molecular Weight: 89.09
- InChI Key: SXQFCVDSOLSHOQ-UWTATZPHSA-N
- InChI: InChI=1S/C3H7NO2/c1-2(5)3(4)6/h2,5H,1H3,(H2,4,6)/t2-/m1/s1
| Assay | Pack Size | Price | Stock | Action |
|---|---|---|---|---|
| 98% | 1g | N/A | N/A | |
| 98% | 5g | N/A | N/A | |
| 98% | Bulk Quantity | N/A | N/A |
| Product_Name: | (R)-(+)-2-Hydroxypropionamide |
|---|---|
| Flash_Point: | 124.3ºC |
| Melting_Point: | 50-53ºC |
| FW: | 89.09320 |
| Density: | 1.161g/cm3 |
| CAS: | 598-81-2 |
| Bolling_Point: | 281.9ºC at 760 mmHg |
| MF: | C3H7NO2 |
| Molecular_Structure: | ['五分子性质数据 ', '1 . Molar refractive index 2100 ', '2 . Molar volume (m3/mol)767 ', '3 . Parachor (902K)1997 ', '4 . Surface tension 458 ', '5 . Polarizability (10 -24cm 3)832'] |
|---|---|
| Flash_Point: | 124.3ºC |
| FW: | 89.09320 |
| Density: | 1.161g/cm3 |
| Bolling_Point: | 281.9ºC at 760 mmHg |
| Computational_Chemistry: | ['1. XlogP :-11 ', '2. Hydrogen Bond Donor Count :2 ', '3. Hydrogen Bond Acceptor Count :2 ', '4. Rotatable Bond Count :1 ', '5. Isotope Atom Count :5 ', '6. TPSA 633 ', '7. Heavy Atom Count :6 ', '8. Topological Polar Surface Area :0 ', '9. Complexity :618 ', '10. Isotope Atom Count :0 ', '11. Defined Atom Stereocenter Count :1 ', '12. Undefined Atom Stereocenter Count :0 ', '13. Defined Bond Stereocenter Count :0 ', '14. Undefined Bond Stereocenter Count :0 ', '15. Covalently-Bonded Unit Count :1'] |
| Melting_Point: | 50-53ºC |
| PSA: | 63.32000 |
| MF: | C3H7NO2 |
| More_Info: | ['一物性数据 ', '1 . Melting point(ºC)50-53ºC ', '2 . Refractive index205(lit)'] |
| Exact_Mass: | 89.04770 |
| RIDADR: | NONH for all modes of transport |
|---|---|
| Risk_Statements(EU): | R23/24/25 |
| Safety_Statements: | S24/25 |
Related Products
(2,3,4,5,6-pentafluorophenyl) 2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]acetate
(3S,6S,9S,12R,15R,18S,21S,24R)-3,6-dibenzyl-12,24-bis[(2R)-butan-2-yl]-15-(2-hydroxypropan-2-yl)-4,10,16,22-tetramethyl-18-(2-methylpropyl)-9,21-di(propan-2-yl)-13-oxa-1,4,7,10,16,19,22,25-octazabicyclo[25.3.0]triacontane-2,5,8,11,14,17,20,23,26-nonone
3-[[(4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-2-oxo-3-[[3-(1,3-thiazol-2-ylcarbamoyl)phenyl]methyl]-1,3-diazepan-1-yl]methyl]-N-(1,3-thiazol-2-yl)benzamide
2H-Pyrido[4,3-b]indole-2-carboxylic acid, 6-bromo-1,3,4,4a,5,9b-hexahydro-, ethyl ester, (4aS,9bR)-
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-3-methyl-, (6bR,10aS)